Lenvatinib and Capecitabine in Patients With Advanced Malignancies

Clinical trial NCT02915172 · WITHDRAWN

Trial details

NCT number: NCT02915172
Sponsor: M.D. Anderson Cancer Center
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer Malignant Neoplasm of Breast Malignant Neoplasms of Bone and Articular Cartilage Malignant Neoplasms of Digestive Organs Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System Malignant Neoplasms of Female Genital Organs Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites Malignant Neoplasms of Independent (Primary) Multiple Sites Malignant Neoplasms of Lip Oral Cavity and Pharynx Malignant Neoplasms of Male Genital Organs Malignant Neoplasms of Mesothelial and Soft Tissue Malignant Neoplasms of Respiratory and Intrathoracic Organs

Start date: 2016-12-01
Primary completion: 2022-12-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.